From: The influence of anemia on one-year exacerbation rate of patients with COPD-PH
Variables | COPD-PH-anemia (n = 40) | COPD-PH (n = 42) | COPD-anemia (n = 48) | COPD (n = 50) |
---|---|---|---|---|
HR (95%CI), P value | HR (95%CI), P value | HR (95%CI), P value | HR (95%CI), P value | |
FEV1-per decrease of 10% | 2.565(1.225–3.764) 0.003 | 2.439(1.219–3.664) 0.002 | 2.108(1.321–4.214) 0.005 | 1.884(0.871–3.265) 0.003 |
AE history-per increase of 1 time | 3.338(1.532–4.698) <0.001 | 3.157(1.339–5.310)< 0.001 | 2.541(1.210–4.311)0.001 | 2.226(1.722–3.827)0.001 |
GOLD-per progression of 1 stage | 2.765(1.555–3.827)0.008 | 2.672(1.246–3.981)0.005 | 2.519(1.433–3.646)0.001 | 1.987(0.592–3.218)0.037 |
Group-per progression of 1 level | 3.102(1.426–3.223) <0.001 | 2.453(1.002–3.528)0.002 | 2.313(1.038–3.297)0.004 | 2.124(0.762–3.281)0.014 |
PaO2-per decrease of 10 mmHg | 2.384(1.542–3.456)0.02 | 2.176(1.256–3.642)0.006 | 2.987(1.777–3.562)0.007 | 1.733(0.888–3.213)0.028 |
Peak VO2-per decrease of 10 ml/min/kg | 2.182(1.214–3.628)0.003 | 2.815(1.118–3.823)0.033 | 2.143(1.143–3.427)0.004 | 2.054(1.076–3.665)0.029 |
6MWD-per decrease of 100 m | 1.676(0.662–3.186)0.036 | 1.501(0.855–3.222)0.044 | 1.453(0.337–3.212)0.038 | 1.222(0.443–3.251)0.057 |
Hemoglobin -per decrease of 1 g/dL− 1 | 3.121(2.325–5.981) <0.001 | 1(reference) | 2.756(1.985–3.784) <0.001 | 1(reference) |
Carboxyhemoglobin-per increase of 0.1 g/dL−1 | 2.838(1.698–5.210)0.001 | 2.663(1.520–3.228)0.001 | 2.437(1.265–3.884)0.001 | 1.688(1.104–3.651)0.002 |